UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter. The dividend is payable on July 5 to all shareholders of record as of June 15, according to a company news release. At its […]
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20
cents a share for the latest quarter.
The dividend is payable on July 5 to all shareholders of record as of June 15, according to a company news release.
At its current stock price, the dividend yields about 1.6 percent on an annual basis.
ConMed specializes in surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.
The firm has a direct selling presence in 17 countries and international sales account for about half of its total sales. Headquartered in Utica, ConMed employs about 3,300 people worldwide.
ConMed reported a net loss of $4.5 million in the first quarter of this year, compared to a net loss of $2.3 million in the first quarter of 2016. The company generated nearly $187 million in revenue in the latest quarter.
